Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
23.4M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
5.95M
-
Shares change
-
-252K
-
Total reported value, excl. options
-
$319K
-
Value change
-
+$62.5K
-
Number of buys
-
3
-
Number of sells
-
-5
-
Price
-
$0.04
Significant Holders of Envoy Medical, Inc. - Class A Common Stock (COCHW) as of Q3 2025
38 filings reported holding COCHW - Envoy Medical, Inc. - Class A Common Stock as of Q3 2025.
Envoy Medical, Inc. - Class A Common Stock (COCHW) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.95M shares
of 23.4M outstanding shares and own 25.42% of the company stock.
Largest 10 shareholders include ARISTEIA CAPITAL, L.L.C. (1.06M shares), Sandia Investment Management LP (590K shares), TORONTO DOMINION BANK (535K shares), Clear Street Group Inc. (431K shares), Polar Asset Management Partners Inc. (297K shares), BNP PARIBAS FINANCIAL MARKETS (283K shares), Bracebridge Capital, LLC (262K shares), Diametric Capital, LP (258K shares), JANE STREET GROUP, LLC (208K shares), and Sculptor Capital LP (182K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.